250 related articles for article (PubMed ID: 34040602)
1. Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer Patient.
Chen M; Zhang L; Zhong W; Zheng K; Ye W; Wang M
Front Immunol; 2021; 12():619147. PubMed ID: 34040602
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report.
Taguchi S; Koshikawa Y; Ohyama S; Miyachi H; Ozawa H; Asada H
BMC Nephrol; 2019 Feb; 20(1):43. PubMed ID: 30727973
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy.
Hara S; Tsuji T; Fukasawa Y; Hisano S; Morito S; Hyodo T; Goto S; Nishi S; Yoshimoto A; Itoh T
Virchows Arch; 2019 Jun; 474(6):735-743. PubMed ID: 30868298
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption.
Weinmann-Menke J; Holtz S; Sollinger D; Dörken M; Boedecker S; Schamberger B; Pfister F; Amann K; Lutz J
Am J Kidney Dis; 2019 Dec; 74(6):849-852. PubMed ID: 31451329
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma.
Ratanasrimetha P; Reddy VD; Kala J; Tchakarov A; Glass WF; Msaouel P; Lin JS
Front Immunol; 2022; 13():898811. PubMed ID: 35967405
[TBL] [Abstract][Full Text] [Related]
6. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
[TBL] [Abstract][Full Text] [Related]
7. Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy.
Reinhard L; Thomas C; Machalitza M; Lattwein E; Weiss LS; Vitu J; Wiech T; Stahl RAK; Hoxha E
Sci Rep; 2021 Aug; 11(1):16188. PubMed ID: 34376704
[TBL] [Abstract][Full Text] [Related]
8. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.
Hoxha E; Beck LH; Wiech T; Tomas NM; Probst C; Mindorf S; Meyer-Schwesinger C; Zahner G; Stahl PR; Schöpper R; Panzer U; Harendza S; Helmchen U; Salant DJ; Stahl RA
J Am Soc Nephrol; 2017 Feb; 28(2):520-531. PubMed ID: 27436855
[TBL] [Abstract][Full Text] [Related]
9. Recurrent membranous nephropathy with a possible alteration in the etiology: a case report.
Matsumoto A; Matsui I; Mano K; Mizuno H; Katsuma Y; Yasuda S; Shimada K; Inoue K; Oki T; Hanai T; Kojima K; Kaneko T; Isaka Y
BMC Nephrol; 2021 Jul; 22(1):253. PubMed ID: 34229600
[TBL] [Abstract][Full Text] [Related]
10. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
Front Immunol; 2018; 9():3035. PubMed ID: 30619370
[TBL] [Abstract][Full Text] [Related]
11. A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy.
Tomas NM; Meyer-Schwesinger C; von Spiegel H; Kotb AM; Zahner G; Hoxha E; Helmchen U; Endlich N; Koch-Nolte F; Stahl RAK
J Am Soc Nephrol; 2017 Nov; 28(11):3262-3277. PubMed ID: 28814510
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study.
Xu Q; Li J; Yang Y; Zhuo L; Gao H; Jiang S; Li W
Ren Fail; 2024 Dec; 46(1):2355353. PubMed ID: 38785304
[TBL] [Abstract][Full Text] [Related]
13. Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway.
Wang Z; Wen L; Dou Y; Zhao Z
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29769410
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy].
Kakhsurueva PA; Kamyshova ES; Bobkova IN; Stavrovskaya EV; Rudenko TE; Andreeva EY
Ter Arkh; 2023 Aug; 95(6):462-467. PubMed ID: 38158964
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of M
Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
[TBL] [Abstract][Full Text] [Related]
17. Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia.
Shirai S; Akiyama S; Kamijo-Ikemori A; Suzuki T; Ichikawa D; Koike J; Kimura K; Shibagaki Y
CEN Case Rep; 2020 Feb; 9(1):65-73. PubMed ID: 31705303
[TBL] [Abstract][Full Text] [Related]
18. Molecular classification of membranous nephropathy.
Pozdzik A; Touzani F; Brochériou I; Corazza F
Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):336-344. PubMed ID: 31045661
[TBL] [Abstract][Full Text] [Related]
19. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F
J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
